Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	12.16	12.56	11.20
Graham Fair Price	-52.34	1.27	2.67
PEG	0.00	0.00	0.00
Price/Book	-16.51	0.79	0.94
Price/Cash Flow	106.63	65.74	31.82
Prices/Earnings	236.57	16.14	-4.80
Price/Sales	-19.35	2.05	2.54
Price/FCF	106.63	65.74	31.82
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	-2.28	0.46	0.47
Operating Margin	-45.01	0.07	0.13
ROA	-76.63	< 0.005	-0.04
ROE	-0.05	0.01	-75.19
ROIC	0.06	0.02	-71.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	0.00	0.00
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	48.73	58.84	20.73
Inventory Turnover	0.00	190000000.00	100.00
Debt/Capitalization	0.06	0.11	84.99
Quick Ratio	1.51	1.53	1.78
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	2.54	2.43	-4.30
Cash	0.20	0.17	-11.88
Capex	-0.05	-0.06	-40.94
Free Cash Flow	0.08	0.03	-61.33
Revenue	0.95	0.94	-0.92
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	1.59	1.54	-2.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.12	1.10	833.76
Naive Interpretation	Member

06 - Financial Health · Weak

Rating